Natixis Advisors
CDNA icon

Natixis Advisors’s CareDx CDNA Stock Holding History

Natixis Advisors’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,658
Closed -$485K – 1427
2021
Q4 		$485K Buy
+10,658
New +$556K ﹤0.01% 1246
2021
Q3 		– Sell
-11,007
Closed -$1.01M – 1316
2021
Q2 		$1.01M Buy
+11,007
New +$875K ﹤0.01% 1091

Other funds holding CDNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Natixis Advisors's CDNA Position: Q1 2022 in Review

Natixis Advisors sold out of CareDx (CDNA) in Q1 2022, closing a stake of 10,658 shares — an estimated $485K sold.

Natixis Advisors first reported a position in CDNA in Q2 2021 and held it in 2 quarters. The position peaked at $1.01M in Q2 2021. 213 funds tracked by Wall St. Rank hold CDNA as of Q1 2022.

  • Natixis Advisors reported no remaining CareDx position as of Q1 2022 after selling out during the quarter.
  • Natixis Advisors sold 10,658 CareDx shares in Q1 2022, an estimated $485K.
  • Natixis Advisors first reported a position in CareDx in Q2 2021 and held it in 2 quarters.
  • Natixis Advisors's CareDx position peaked at $1.01M in Q2 2021.
  • 213 funds tracked by Wall St. Rank held CareDx as of Q1 2022.

Based on Natixis Advisors's 13F filing for Q1 2022, filed 12 May 2022.